United States Hydronephrosis Market 2025 | Unilateral hydronephrosis leads with 62% share due to higher prevalence and common presentation in adults and children

Leander, Texas and Tokyo, Japan - Dec.04.2025
As per DataM intelligence research report" Hydronephrosis market size is growing at a high CAGR during the forecast period (2022-2029)" Improved imaging and growing awareness of kidney health are supporting effective diagnosis and management of hydronephrosis.

Download your exclusive sample report today: (corporate email gets priority access):
https://www.datamintelligence.com/download-sample/hydronephrosis-market?Prasad

United States: Recent Industry Developments

✅ In November 2025, Boston Scientific launched a "smart" ureteral stent for treating hydronephrosis The stent changes color or signals when it becomes encrusted or infected preventing complications It represents a leap forward in the management of chronic urinary obstruction

✅ In September 2025, The FDA cleared a new robotic-assisted surgical system for pyeloplasty procedures The system allows for ultra-precise reconstruction of the kidney pelvis to relieve hydronephrosis It makes minimally invasive correction of kidney blockages more accessible in U.S. hospitals

✅ In July 2025, Cleveland Clinic researchers published a study on using AI to predict hydronephrosis severity from ultrasound The algorithm helps urologists decide which patients need urgent intervention versus observation It optimizes clinical decision-making and resource utilization in U.S. healthcare

✅ In May 2025, a patient advocacy group launched a national awareness campaign on antenatal hydronephrosis The campaign educates expectant parents on monitoring and managing kidney dilation in fetuses It provides support and resources for U.S. families facing this common birth defect

Japan: Recent Industry Developments

✅ In October 2025, Olympus Corporation introduced a new flexible ureteroscope specifically for pediatric hydronephrosis The slim design allows for easier navigation in the smaller urinary tracts of children It improves the safety and efficacy of endoscopic treatments for Japanese pediatric patients

✅ In August 2025, a Japanese university hospital successfully performed a remote robotic surgery for hydronephrosis The surgeon operated from a distant city using 5G technology to relieve a kidney obstruction It demonstrates the potential of telesurgery to treat patients in rural Japan

✅ In June 2025, Terumo released a hydrophobic-coated nephrostomy tube that reduces bacterial adhesion The tube is designed for long-term drainage of kidneys in patients with terminal hydronephrosis It reduces the frequency of tube exchanges and infection risk for Japanese patients

✅ In April 2025, The Japanese Urological Association updated its clinical guidelines for the follow-up of asymptomatic hydronephrosis The guidelines recommend specific imaging intervals to minimize radiation exposure It standardizes the long-term management of kidney dilation across Japan

Hydronephrosis Market: Drivers
The hydronephrosis market is growing as increasing prevalence of kidney disorders, urinary tract obstructions, and congenital anomalies drives demand for diagnostic and therapeutic solutions. Hydronephrosis requires timely imaging, monitoring, and intervention to prevent kidney damage, with treatments ranging from medication and stent placement to surgical procedures. Advancements in ultrasound, CT imaging, and minimally invasive techniques are improving detection and patient outcomes. Increased awareness of urological health and early diagnosis initiatives are supporting market growth.

Collaboration among urologists, nephrologists, and diagnostic imaging centers is accelerating development of effective treatment pathways. Growth in pediatric urology, geriatric kidney care, and hospital infrastructure is expanding treatment availability. Integration of digital imaging systems, AI-driven diagnostics, and remote monitoring tools is enhancing clinical precision. With rising kidney-related conditions, improved healthcare access, and continuous innovation, the hydronephrosis market is positioned for long-term expansion.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/hydronephrosis-market?Prasad

Hydronephrosis Market: Major Players
Lupin Pharmaceuticals, Inc., Pfizer Inc., Bayer HealthCare Pharmaceuticals Inc., GlaxoSmithKline plc., Mallinckrodt Pharmaceuticals, Johnson & Johnson Consumer Inc., Roche Laboratories Inc., Teva Pharmaceuticals USA, Inc.

Segment Covered in the Hydronephrosis Market:
By Type
Unilateral hydronephrosis leads with 62% share due to higher prevalence and common presentation in adults and children. Bilateral hydronephrosis holds 38%, typically seen in congenital cases or severe urinary obstruction requiring specialized care.

By Diagnosis
Ultrasound dominates with 41% share as a first-line, non-invasive diagnostic tool. CT scan accounts for 25%, supported by detailed imaging for obstruction and planning interventions. MRI holds 15%, while blood tests and urine tests collectively represent 14%, and others 5%, including nuclear imaging and contrast studies.

By Treatment
Surgery leads with 33% share, especially for severe obstruction or congenital anomalies. Shock wave lithotripsy accounts for 20%, followed by ureteroscopy 17%, laparoscopy 10%, bladder catheterization 8%, steroid therapy 5%, medications 4%, and others 3%, reflecting supportive and emerging therapies.

By Distribution Channel
Hospital pharmacies dominate with 52% share due to inpatient treatments and surgical procedures. Retail pharmacies hold 31%, supplying medications and supportive care. Online pharmacies account for 12%, while other channels represent 5%, including specialized health centers.

By End-User
Hospitals lead with 48% share, performing complex surgical and interventional procedures. Clinics hold 21%, managing outpatient follow-ups. Diagnostic centers capture 16%, ambulatory surgical centers 10%, and others 5%, including home care and rehabilitation facilities.

Regional Analysis
North America - 34%
North America leads with 34% share due to advanced imaging facilities, high surgical adoption, and strong healthcare infrastructure.

Europe - 28%
Europe holds 28%, supported by widespread diagnostic adoption, minimally invasive procedures, and high awareness of urological disorders.

Asia Pacific - 27%
Asia Pacific accounts for 27%, driven by increasing hospital infrastructure, growing geriatric population, and rising congenital hydronephrosis cases.

Latin America - 6%
Latin America contributes 6%, supported by improving hospital care and diagnostic services in Brazil and Mexico.

Middle East & Africa - 5%
MEA holds 5%, driven by emerging urology centers, growing awareness, and adoption of modern diagnostic and treatment technologies.

Purchase this report before year-end and unlock an exclusive 30% discount:
https://www.datamintelligence.com/buy-now-page?report=hydronephrosis-market
(Purchase 2 or more Repots and get 50% Discount)

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?Prasad

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.